LY2969822: Pharmacological Characterization of an Orally Bioavailable Prodrug for a Potent, Selective mGlu2/3 Receptor AgonistD. L. McKinzie,B. J. Johnson, K. Knitowski,D. Shaw, L. Rorick-Kehn, J. Katner,K. Perry,S. Swanson, J. Catlow,M. P. Johnson,L. Prieto, C. Beadle,J. A. MonnCURRENT NEUROPHARMACOLOGY（2014）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
